|Bid||0.2600 x N/A|
|Ask||0.2750 x N/A|
|Day's Range||0.2600 - 0.2700|
|52 Week Range||0.2550 - 1.0800|
|Beta (3Y Monthly)||6.32|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
InMed Pharmaceuticals Inc. (TSE:IN) shareholders might understandably be very concerned that the share price has...
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. So we'll take...
Liht Cannabis (CSE: LIHT) (OTCQX: LIHTF) reported the preliminary results of its first harvest in Las Vegas, Nev. The company started harvesting the first of its six cultivation rooms earlier this month. Room One, comprised of popular strains such as Bubba Kush, Moonshine Ghost Train Haze, Amherst Sour Diesel, Skywalker and Lemon Skunk, has produced […]The post Cannabis Stock News Daily Roundup February 13 appeared first on Market Exclusive.
The global legal cannabis market is projected to hit $146.4 billion by end of 2025, according to research by Grand View Research. The legal cannabis industry is gaining traction worldwide due to high demand among consumers for recreational and medical products. Recreational cannabis spending is projected to hit $35 Billion mark, while medical cannabis spending […] The post Cannabis Stock News Daily Roundup December 5 appeared first on Market Exclusive.
Anyone researching InMed Pharmaceuticals Inc (TSE:IN) might want to consider the historical volatility of the share price. Volatility is considered to be a measure of risk in modern finance theory. Read More...